La anemia hemolítica autoinmune (AHAI) es una enfermedad poco frecuente en la edad pediátrica. Su diagnóstico se establece mediante la prueba de. La asociación de colitis ulcerosa (CU) y anemia hemolítica autoimmune (AHAI) se describió por primera vez a principios de la década de los cincuenta; sin. Se estudiaron 13 pacientes con leucemia mieloide crónica y anemia hemolítica autoinmune inducida por el interferón alfa, a quienes se les realizó la detección.

Author: Akikazahn Negami
Country: South Africa
Language: English (Spanish)
Genre: Personal Growth
Published (Last): 27 February 2016
Pages: 103
PDF File Size: 9.21 Mb
ePub File Size: 20.56 Mb
ISBN: 356-9-94777-959-2
Downloads: 35807
Price: Free* [*Free Regsitration Required]
Uploader: Kelar

Si continua navegando, consideramos que acepta su uso.

Recently, rituximab has been shown to be an alternative treatment option in children as well as in adults for relapsed and refractory autoimmune haemolytic anaemias and in patients who are medically unsuited for espenectomy. Br J Haematol,pp. Raanani P, Ben-Bassat I. Therefore, properly designed clinical trials evaluating rituximab as salvage- and first-line-therapy for the treatment of AIHA and cold agglutinin disease are clearly warranted.

Subscribe to our Newsletter. Clinical Practice Guidelines for the Treatment of Systemic The role of rituximab in adults with warm antibody autoimmune hemolytic anaemia. Immune-mediated and unusual complications during interferon alpha therapy in chronic myelogenous leukemia. ApartadoCP American Red Cross; Published studies hemolitca primarily clinical and epidemiological research but also basic.


Anemia Hemolítica Autoinmune

Immune-mediated complications during interferon therapy in hematological patients. Best Pract Res Clin Haematol. Am J Hematol, 84pp. Lower dose of rituximab in the treatment of elderly autoinmune hemolytic anemia. It was detected the presence of IgG anemiw C3 in Lupus, 24pp. Treatment of AIHA, especially in cold antibody-mediated disease, represents a therapeutical challenge. There was a negative correlation between Hb and plasma haptoglobin values with the number of IgG molecules per erythrocyte and a positive correlation between the latter with the reticulocyte count.

Anemia Hemolítica Autoinmune | Medical City McKinney

Jonasch E, Haluska FG. CiteScore measures average citations received per document published. The mechanism of action appears to be linked with the selective B-cell depletion and the lowering of autoantibody levels.

Autojnmune PAD y la Mp fueron negativas en un caso. A variety of other immunosuppressive agents as well as splenectomy are used for refractory cases. Retrospective analysis of 27 cases. Key words autoimmune haemolytic anaemia, cold agglutinin disease, rituximab. Petz LD, Garraty G.


Controlling autoimmunity–Lessons from the study of red blood cells as model antigens. Ann Hematol, 89pp.

Most 10 Related  GAR 7 CHALLAN PDF

Rituximab therapy has a rapid and durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus. To improve our services and products, we use “cookies” own or third parties authorized to show advertising related to client preferences through the analyses of navigation customer behavior.

Rev Cubana Hematol Inmunol Hemoter, 29pp. Blood,pp. American Association of Blood Banks; SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

There was a problem providing the content you requested

Quantitation of red cell-bound IgG, IgA, and IgM in patients with autoimmune hemolytic anemia and blood donors by enzyme-linked immunosorbent assay.

Rituximab in the treatment of autoinmune haematological disorders. Continuing navigation will be considered as acceptance of this use. Successful induction and maintenance of long-term remission in a child with chronic relapsing autoinmune hemolytic anemia using rituximab. Br J Clin Pharmacol, 79pp. Rheumatoid Arthritis and Ocular Myasthenia Gravis Normal outcome of pregnancy in chronic myeloid leukemia treated with interferon-alpha in 1st trimester: